Westminster, Colo.-based Cerapedics' i-Factor bone graft is designed to enhance spinal outcomes for cervical spine fusion, according to Medical Device and Diagnostic Industry.
Here are four key points:
1. The bone graft is composed of a synthetic small peptide and anorganic bone mineral.
2. i-Factor fosters a favorable environment that enhances cell attachment to the ABM scaffold.
3. The FDA approved i-Factor, which is the first approved bone graft for the cervical spine.
4. In a clinical trial, i-Factor demonstrated a 69 percent success rate for all four outcomes compared to a 57 percent success rate for autograft.
More articles on devices:
St. Jude Medical launches Axium Neurostimulator System — 5 highlights
JRI Orthopaedics, RESTORATION develop 3D printed bioceramic implant — 4 highlights
Stryker Spine acquires SafeWire, builds on MIS presence — 5 things to know